Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 216,963 |
|
|||||
| News | - | ||||||
| Day High | 7.37 | Low High |
|||||
| Day Low | 7.095 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Larimar Therapeutics Inc | LRMR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.045 | -0.62% | 7.255 | 12:55:40 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.22 | 7.095 | 7.37 | 7.30 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,374 | 216,963 | $ 7.30 | $ 1,583,074 | - | 2.18 - 13.68 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:55:20 | 2 | $ 7.245 | USD |
Larimar Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 63.16M | 63.80M | - | 0 | -36.95M | -0.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Larimar Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LRMR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.29 | 7.495 | 6.79 | 7.05 | 311,669 | -0.035 | -0.48% |
| 1 Month | 8.41 | 8.91 | 6.79 | 7.65 | 455,209 | -1.16 | -13.73% |
| 3 Months | 4.34 | 13.68 | 4.19 | 9.68 | 664,759 | 2.92 | 67.17% |
| 6 Months | 2.96 | 13.68 | 2.18 | 8.66 | 374,351 | 4.30 | 145.10% |
| 1 Year | 4.53 | 13.68 | 2.18 | 6.73 | 310,301 | 2.73 | 60.15% |
| 3 Years | 11.57 | 15.49 | 1.53 | 6.23 | 206,975 | -4.32 | -37.29% |
| 5 Years | 12.00 | 25.87 | 1.53 | 6.93 | 169,723 | -4.75 | -39.54% |
Larimar Therapeutics Description
| Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia. |
